SPECTRUM AND SEVERITY OF ADVERSE DRUG REACTIONS DURING TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS. International Research Journal of Pharmacy, [S. l.], v. 17, n. 9, p. 11–17, 2026. DOI: 10.56802/cyzkpf46. Disponível em: https://irjponline.org/index.php/irjp/article/view/3667. Acesso em: 20 sep. 2026.